RENAGADE
Live / Registered — Registered (as of 24 Mar 2026)
What this means for you
Registered since 24 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90537289
- Registration number
- 8187836
- Mark type
- Stylized text
- Filed
- 20 Feb 2021
- Published for opposition
- 17 Jan 2023
- Registered
- 24 Mar 2026
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 042 — Scientific and technological services: medical and scientific research in the field of cancer treatment; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines, namely, RNA vaccines; research and development services in the field of antibodies; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the field of nucleic acids, namely, RNA therapeutics for use in the treatment of rare diseases, cancers, inflammatory disorders, immunoregulatory disorders, infectious diseases, blood disorders; scientific research in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids; pharmaceutical research and development; product research and development; scientific research and development; vaccine research and development in the field of RNA vaccines
Owner
- Renagade Therapeutics LLC, Watertown, MA, US
- Renagade Therapeutics LLC, Watertown, MA, US
- Renagade Therapeutics LLC, Cambridge, MA, US
Prosecution history
- 24 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 05 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Mar 2026 — USE AMENDMENT FILED
- 04 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 29 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Dec 2025 — SOU EXTENSION 5 GRANTED
- 11 Aug 2025 — SOU EXTENSION 5 FILED
- 29 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 4 GRANTED
- 12 Feb 2025 — SOU EXTENSION 4 FILED